The judges’s decision cancels the previously scheduled hearing, set to begin next week, during which time proponents and opponents of marijuana rescheduling were to testify and face cross-examination.
Category: GOVERNMENT
Since 2020, over 139,000 commercially licensed truckers have tested positive on urine tests for past cannabis exposure, resulting in an industry-wide labor shortage.
DEA Administrative Law Judge John Mulrooney has ordered witness testimony to begin on Tuesday, January 21, 2025.
NORML’s Deputy Director Paul Armentano said that he was disappointed but hardly surprised by the DEA’s decision to disproportionately include groups opposed to marijuana policy reform as designated participants. “The fight to end our nation’s outdated and failed cannabis prohibition laws has never been fought on a level playing field,” he said.
“We believe NORML has well earned a seat at the table, and that it is in the public interest for it to be heard.”
Nearly 40 years ago, advocates made the case to the DEA’s own judge that cannabis did not meet the definition of a Schedule I controlled substance. Their case is exponentially stronger now.
The hearing is scheduled to commence on Monday, December 2, 2024.
“Nurses have long known through their own first hand experience working with patients that cannabis holds legitimate therapeutic value. That is why, historically, nurses and nursing groups have been among some of the strongest and most outspoken advocates for changes in marijuana policy.”